Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039759 | SCV000063448 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Pro1805Leu in Exon 33 of PCDH15: This variant is not expected to have clinical s ignificance because it has been identified in 0.6% (23/3736) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs114137983). |
Eurofins Ntd Llc |
RCV000039759 | SCV000203201 | likely benign | not specified | 2015-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000971054 | SCV000729391 | likely benign | not provided | 2021-07-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000971054 | SCV001118670 | likely benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001105923 | SCV001262938 | uncertain significance | Usher syndrome type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
ARUP Laboratories, |
RCV000971054 | SCV003799630 | likely benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000971054 | SCV004125387 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | PCDH15: BP4 |
Natera, |
RCV001831689 | SCV002079571 | likely benign | Usher syndrome type 1F | 2019-12-12 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004534846 | SCV004731416 | likely benign | PCDH15-related disorder | 2020-12-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |